Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
119000,,,5149787,[],CHEMBL1662502,Antibacterial activity against mprF and ugtP gene-deficient Bacillus subtilis CU1065 mutant by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.6
119001,,,5149788,[],CHEMBL1662503,Antibacterial activity against mprF and pssA gene-deficient Bacillus subtilis CU1065 mutant by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.9
119002,,,5149789,[],CHEMBL1662504,Antibacterial activity against psd and mprF gene-deficient Bacillus subtilis CU1065 mutant by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.9
119003,,,5149790,[],CHEMBL1660544,Antibacterial activity against mprF and pspA gene-deficient Bacillus subtilis CU1065 mutant by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.5
119004,,,5149791,[],CHEMBL1660678,Antibacterial activity against Bacillus subtilis CU1065 mutant with mprF gene overexpression by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,1.3,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.3
119005,,,5149792,[],CHEMBL1660679,Antibacterial activity against Bacillus subtilis CU1066 with depletion in pgsA gene by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,8.0
119006,,,5149793,[],CHEMBL1660680,Antibacterial activity against Bacillus subtilis CU1065 harboring IPTG-induced pgsA by liquid growth inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649137,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325698,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
119007,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5151380,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1657058,"Cmax in New Zealand rabbit at 12 mg/kg/day, iv for 4 days measured after 15 mins post last dose by HPLC",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325713,=,1,1,=,,Cmax,nM,,63738.28,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,103.3
119008,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5151381,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '18.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '18.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1657059,"Cmax in New Zealand rabbit at 18 mg/kg/day, iv for 4 days measured after 15 mins post last dose by HPLC",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325713,=,1,1,=,,Cmax,nM,,91751.04,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,148.7
119009,,,5151382,[],CHEMBL1657060,"Half life in New Zealand rabbit at 12 mg/kg/day, iv for 4 days by HPLC",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325713,=,1,1,=,,T1/2,hr,,5.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,5.0
119010,,,5151383,[],CHEMBL1657061,"Half life in New Zealand rabbit at 18 mg/kg/day, iv for 4 days by HPLC",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325713,=,1,1,=,,T1/2,hr,,5.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,5.0
119011,,,5151384,[],CHEMBL1657062,"AUC in New Zealand rabbit at 12 mg/kg/day, iv for 4 days by HPLC",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,1,=,,AUC,ng.hr.mL-1,,719000.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,microg.hr/mL,,,719.0
119012,,,5151385,[],CHEMBL1657063,"AUC in New Zealand rabbit at 18 mg/kg/day, iv for 4 days by HPLC",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,1,=,,AUC,ng.hr.mL-1,,965000.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,microg.hr/mL,,,965.0
119013,,,5151386,[],CHEMBL1657064,"AUC in human at 6 mg/kg, iv by HPLC",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,1,=,,AUC,ng.hr.mL-1,,632000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,632.0
119014,,,5151387,[],CHEMBL1657065,"AUC in human at 10 mg/kg, iv by HPLC",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,1,=,,AUC,ng.hr.mL-1,,1039000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,1039.0
119015,,,5151388,[],CHEMBL1657067,Antimicrobial activity against rifampin-susceptible Staphylococcus aureus A by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325713,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
119016,,,5151389,[],CHEMBL1657068,Antimicrobial activity against rifampin-resistant Staphylococcus aureus B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325713,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
119017,,,5151390,[],CHEMBL1657069,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count in endocardial vegetation at 12 mg/kg/day, iv for 4 days (Rvb = 7.8+/-0.4 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,5.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,5.3
119018,,,5151391,[],CHEMBL1657070,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 6.0+/-0.3 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,1.0
119019,,,5151392,[],CHEMBL1657071,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count in kidney at 12 mg/kg/day, iv for 4 days (Rvb = 6.3+/-1.0 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,604.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,604.0
119020,,,5151393,[],CHEMBL1657072,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain A0.5 in endocardial vegetation at 12 mg/kg/day, iv for 4 days (Rvb = 280 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.3
119021,,,5151394,[],CHEMBL1657073,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain A0.5 in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 333 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,1.0
119022,,,5151395,[],CHEMBL1657074,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain A0.5 in kidney at 12 mg/kg/day, iv for 4 days (Rvb =360 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,175.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,175.0
119023,,,5151396,[],CHEMBL1657075,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain B2.0 in endocardial vegetation at 12 mg/kg/day, iv for 4 days (Rvb = 320 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,1.7
119024,,,5151397,[],CHEMBL1657076,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain B2.0 in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 627 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119025,,,5151398,[],CHEMBL1657219,"Antimicrobial activity against Staphylococcus aureus A0.5/B2.0 infected in New Zealand rabbit dual-infection aortic valve endocarditis model assessed as bacterial count of strain B2.0 in kidney at 12 mg/kg/day, iv for 4 days (Rvb = 240 log10 CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,156.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,156.0
119026,,,5151399,[],CHEMBL1657220,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in endocardial vegetation at 12 mg/kg/day, iv for 4 days (Rvb = 6.9+/-0.7 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119027,,,5151400,[],CHEMBL1657221,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in endocardial vegetation at 18 mg/kg/day, iv for 4 days (Rvb = 6.9+/-0.7 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119028,,,5151401,[],CHEMBL1657222,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 6.1+/-0.2 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119029,,,5151402,[],CHEMBL1657223,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 18 mg/kg/day, iv for 4 days (Rvb = 6.1+/-0.2 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119030,,,5151403,[],CHEMBL1657224,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 5.7+/-0.7 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119031,,,5151404,[],CHEMBL1657225,"Antimicrobial activity against Staphylococcus aureus A0.5 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 18 mg/kg/day, iv for 4 days (Rvb = 5.7+/-0.7 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,0.0
119032,,,5151405,[],CHEMBL1657226,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in endocardial vegetation at 12 mg/kg/day, iv for 4 days (Rvb = 7.3+/-1.0 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,6.3
119033,,,5151406,[],CHEMBL1657227,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in endocardial vegetation at 18 mg/kg/day, iv for 4 days (Rvb = 7.3+/-1.0 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,4.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,4.4
119034,,,5151407,[],CHEMBL1657228,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 12 mg/kg/day, iv for 4 days (Rvb = 5.4+/-0.2 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,3.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,3.2
119035,,,5151408,[],CHEMBL1657229,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in spleen at 18 mg/kg/day, iv for 4 days (Rvb = 5.4+/-0.2 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.3
119036,,,5151409,[],CHEMBL1657230,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in kidney at 12 mg/kg/day, iv for 4 days (Rvb = 5.1+/-0.6 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.1
119037,,,5151410,[],CHEMBL1657231,"Antimicrobial activity against Staphylococcus aureus B2.0 infected in New Zealand rabbit aortic valve endocarditis model assessed as bacterial count in kidney at 18 mg/kg/day, iv for 4 days (Rvb = 5.1+/-0.6 log10 CFU/g)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325713,=,1,0,=,,log10CFU/g,,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.5
119038,,,5151411,[],CHEMBL1657066,Antimicrobial activity against rifampin-susceptible Staphylococcus aureus A by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649142,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325713,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
119039,,,5157447,[],CHEMBL1660952,Antimicrobial activity against Staphylococcus aureus isolate 616 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649434,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326317,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
119040,,,5157448,[],CHEMBL1660953,Antimicrobial activity against Staphylococcus aureus isolate 629 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649434,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326317,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119041,,,5157449,[],CHEMBL1660954,Antimicrobial activity against Staphylococcus aureus isolate 701 harboring mprF C884A mutant gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649434,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326317,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
119042,,,5157450,[],CHEMBL1660955,Antimicrobial activity against Staphylococcus aureus isolate 703 harboring mprF C884A mutant gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649434,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326317,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
119043,,,5160049,[],CHEMBL1653755,Antimicrobial activity against Staphylococcus aureus isolate UAMS-1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649440,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326344,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119044,,,5160052,[],CHEMBL1653756,Antimicrobial activity against Staphylococcus aureus isolate UAMS-929 harboring sarA gene mutant by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649440,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326344,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119045,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162070,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655779,"Cmax in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,47819.14,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,77.5
119046,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162071,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655778,"Cmax in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,26112.33,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,42.32
119047,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162072,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655777,"Cmax in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,27136.59,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,43.98
119048,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162073,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655776,"Cmax in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,35632.97,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,57.75
119049,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162074,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655775,"Cmax in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,28555.74,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,46.28
119050,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162075,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655774,"Cmax in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,41340.42,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,67.0
119051,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162076,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655773,"Cmax in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,32837.87,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,53.22
119052,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162077,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655683,"Cmax in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,41525.52,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,67.3
119053,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162078,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655772,"Cmax in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,26099.99,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,42.3
119054,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162079,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655682,"Cmax in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,70167.64,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,113.72
119055,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162080,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655681,"Cmax in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,73012.11,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,118.33
119056,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162081,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655680,"Cmax in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,50595.73,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,82.0
119057,,,5162082,[],CHEMBL1655679,"Plasma concentration in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,3.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.3
119058,,,5162083,[],CHEMBL1655678,"Plasma concentration in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,6.38,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,6.38
119059,,,5162084,[],CHEMBL1655677,"Plasma concentration in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,3.44,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.44
119060,,,5162085,[],CHEMBL1655676,"Plasma concentration in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,3.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.3
119061,,,5162086,[],CHEMBL1655675,"Plasma concentration in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,5.88,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,5.88
119062,,,5162087,[],CHEMBL1655674,"Plasma concentration in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,3.39,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.39
119063,,,5162088,[],CHEMBL1661398,"Plasma concentration in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,6.55,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,6.55
119064,,,5162089,[],CHEMBL1661397,"Plasma concentration in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,3.39,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.39
119065,,,5162090,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661395,"AUC (0 to infinity) in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,529700.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,529.7
119066,,,5162091,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661396,"AUC (0 to infinity) in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,300640.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,300.64
119067,,,5162092,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661394,"AUC (0 to infinity) in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,473660.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,473.66
119068,,,5162093,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661393,"AUC (0 to infinity) in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,420530.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,420.53
119069,,,5162094,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661392,"AUC (0 to infinity) in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,322370.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,322.37
119070,,,5162095,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661391,"AUC (0 to infinity) in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,547780.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,547.78
119071,,,5162096,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661390,"AUC (0 to infinity) in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,418760.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,418.76
119072,,,5162097,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661389,"AUC (0 to infinity) in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,581000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,581.0
119073,,,5162098,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661388,"AUC (0 to infinity) in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,346000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,346.0
119074,,,5162099,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661387,"AUC (0 to infinity) in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,867430.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,867.43
119075,,,5162100,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661385,"AUC (0 to infinity) in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,928020.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,928.02
119076,,,5162101,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661386,"AUC (0 to infinity) in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,598000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,598.0
119077,,,5162102,[],CHEMBL1661384,"Half life in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.74,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.74
119078,,,5162103,[],CHEMBL1661383,"Half life in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,6.79,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.79
119079,,,5162104,[],CHEMBL1661382,"Half life in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,11.85,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,11.85
119080,,,5162105,[],CHEMBL1661381,"Half life in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.34,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.34
119081,,,5162106,[],CHEMBL1662734,"Half life in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,6.83,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.83
119082,,,5162107,[],CHEMBL1662733,"Half life in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.12,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.12
119083,,,5162108,[],CHEMBL1662732,"Half life in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.04,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.04
119084,,,5162109,[],CHEMBL1662731,"Half life in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.68,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.68
119085,,,5162110,[],CHEMBL1662730,"Half life in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.72,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.72
119086,,,5162111,[],CHEMBL1662729,"Half life in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.97,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.97
119087,,,5162112,[],CHEMBL1662728,"Half life in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,9.44,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.44
119088,,,5162113,[],CHEMBL1662727,"Half life in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.06,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.06
119089,,,5162114,[],CHEMBL1662726,"Clearance in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,0,=,,CL,ml/min,,9.84,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min,,,9.84
119090,,,5162115,[],CHEMBL1662725,"Clearance in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.2515,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,15.09
119091,,,5162116,[],CHEMBL1662724,"Clearance in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1643,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.86
119092,,,5162117,[],CHEMBL1662723,"Clearance in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.2707,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,16.24
119093,,,5162118,[],CHEMBL1662722,"Clearance in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.2453,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,14.72
119094,,,5162119,[],CHEMBL1662721,"Clearance in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1303,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.82
119095,,,5162120,[],CHEMBL1662720,"Clearance in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1698,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,10.19
119096,,,5162121,[],CHEMBL1662719,"Clearance in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.0001183,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,0.0071
119097,,,5162122,[],CHEMBL1662718,"Clearance in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.0002,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,0.012
119098,,,5162123,[],CHEMBL1662717,"Clearance in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1183,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.1
119099,,,5162124,[],CHEMBL1662716,"Clearance in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1092,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,6.55
119100,,,5162125,[],CHEMBL1662715,"Clearance in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.171,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,10.26
119101,,,5162126,[],CHEMBL1662714,"Volume of distribution at steady state in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,0,=,,Vdss,ml,,6057.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,ml,UO_0000098,,6057.0
119102,,,5162127,[],CHEMBL1662713,"Volume of distribution at steady state in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.14,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.14
119103,,,5162128,[],CHEMBL1662712,"Volume of distribution at steady state in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.15
119104,,,5162129,[],CHEMBL1662711,"Volume of distribution at steady state in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.15
119105,,,5162130,[],CHEMBL1662710,"Volume of distribution at steady state in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.13
119106,,,5162131,[],CHEMBL1662709,"Volume of distribution at steady state in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.18,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.18
119107,,,5162132,[],CHEMBL1662708,"Volume of distribution at steady state in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.11,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.11
119108,,,5162133,[],CHEMBL1662707,"Volume of distribution at steady state in morbidly obese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.09,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.09
119109,,,5162134,[],CHEMBL1662706,"Volume of distribution at steady state in nonobese human subjects at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.13
119110,,,5162135,[],CHEMBL1662705,"Volume of distribution at steady state in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.08,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.08
119111,,,5162136,[],CHEMBL1662704,"Volume of distribution at steady state in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.08,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.08
119112,,,5162137,[],CHEMBL1662703,"Volume of distribution at steady state in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.12,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.12
119113,,,5162138,[],CHEMBL1662702,"Volume of distribution in central compartment in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,0,=,,Vd,ml,,3420.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,ml,UO_0000098,,3420.0
119114,,,5162139,[],CHEMBL1662701,"Apparent volume of distribution in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,0,=,,Vd,ml,,6350.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,ml,UO_0000098,,6350.0
119115,,,5162140,[],CHEMBL1662700,"Apparent volume of distribution in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.15
119116,,,5162141,[],CHEMBL1662699,"Apparent volume of distribution in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.17,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.17
119117,,,5162142,[],CHEMBL1662698,"Mean residence time in healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,10.94,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,10.94
119118,,,5162143,[],CHEMBL1662697,"Mean residence time in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,9.05,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,9.05
119119,,,5162144,[],CHEMBL1662696,"Mean residence time in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,15.91,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,15.91
119120,,,5162145,[],CHEMBL1662695,"Mean residence time in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,12.04,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,12.04
119121,,,5162146,[],CHEMBL1662694,"Mean residence time in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,12.44,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,12.44
119122,,,5162147,[],CHEMBL1662693,"Drug excretion in healthy human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,59.7,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,59.7
119123,,,5162148,[],CHEMBL1662692,"Drug excretion in young healthy human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,42.29,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,42.29
119124,,,5162149,[],CHEMBL1662691,"Drug excretion in old healthy human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,34.31,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,34.31
119125,,,5162150,[],CHEMBL1662690,"Drug excretion in moderately obese adult human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,51.82,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,51.82
119126,,,5162151,[],CHEMBL1662689,"Drug excretion in nonobese adult human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,52.33,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,52.33
119127,,,5162152,[],CHEMBL1662688,"Drug excretion in morbidly obese adult human urine assessed as unchanged drug at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,42.74,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,42.74
119128,,,5162153,[],CHEMBL1662687,"Drug excretion in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,48.64,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,48.64
119129,,,5162154,[],CHEMBL1662686,"Drug excretion in adult human with hepatic impairment urine assessed as unchanged drug at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,49.27,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,49.27
119130,,,5162155,[],CHEMBL1662685,"Drug excretion in adult human subjects urine assessed as unchanged drug at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,0,=,,Drug uptake,%,,39.81,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,39.81
119131,,,5162156,[],CHEMBL1661242,"Renal clearance in young healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.12,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,7.2
119132,,,5162157,[],CHEMBL1661241,"Renal clearance in old healthy human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.07117,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,4.27
119133,,,5162158,[],CHEMBL1661240,"Renal clearance in moderately obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.1558,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,9.35
119134,,,5162159,[],CHEMBL1661239,"Renal clearance in nonobese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.1395,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,8.37
119135,,,5162160,[],CHEMBL1661238,"Renal clearance in morbidly obese adult human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.1343,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,8.06
119136,,,5162161,[],CHEMBL1661237,"Renal clearance in nonobese human at 4 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.098,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,5.88
119137,,,5162162,[],CHEMBL1661236,"Renal clearance in adult human with hepatic impairment at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.06083,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,3.65
119138,,,5162163,[],CHEMBL1661235,"Renal clearance in adult human subjects at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.04533,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,2.72
119139,,,5162164,[],CHEMBL1661234,"Renal clearance in healthy adult human at 6 mg/kg, iv administered as single dose 30 mins infusion",A,,,BAO_0002773,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.064,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/hr.Kg,,,3.84
119140,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162165,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661233,"Cmax in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,33689.35,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,54.6
119141,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162166,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661232,"Cmax in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,53310.63,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,86.4
119142,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162167,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661231,"Cmax in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,71759.56,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,116.3
119143,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162168,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661586,"Cmax in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,35663.82,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,57.8
119144,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162169,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661585,"Cmax in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,60838.28,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,98.6
119145,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162170,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661584,"Cmax in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,82063.81,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,133.0
119146,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162171,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661583,"Cmax in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,79904.24,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,129.5
119147,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162172,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661582,"Cmax in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,59048.92,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,95.7
119148,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162173,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661581,"Cmax in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,65527.65,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,106.2
119149,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162174,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661580,"Cmax in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,80027.64,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,129.7
119150,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162175,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661579,"Cmax in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,101685.08,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,164.8
119151,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162176,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661578,"Cmax in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,57938.29,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,93.9
119152,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162177,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661577,"Cmax in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,76078.71,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,123.3
119153,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162178,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661576,"Cmax in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,87061.68,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,141.1
119154,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162179,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661575,"Cmax in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,113346.78,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,183.7
119155,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162180,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661574,"Cmax in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,85951.05,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,139.3
119156,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162181,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661573,"Cmax in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,112112.74,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,181.7
119157,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162182,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1661572,"Cmax in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on days 1-3",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,59048.92,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,95.7
119158,,,5162183,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661571,"AUC (0 to infinity) in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,425000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,425.0
119159,,,5162184,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661570,"AUC (0 to infinity) in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,705000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,705.0
119160,,,5162185,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661569,"AUC (0 to infinity) in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1127000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1127.0
119161,,,5162186,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661568,"AUC (0 to infinity) in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,494000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,494.0
119162,,,5162187,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661567,"AUC (0 to infinity) in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,747000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,747.0
119163,,,5162188,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661566,"AUC (0 to infinity) in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1130000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1130.0
119164,,,5162189,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661565,"AUC (0 to infinity) in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1090000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1090.0
119165,,,5162190,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661564,"AUC (0 to infinity) in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,729800.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,729.8
119166,,,5162191,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661563,"AUC (0 to infinity) in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,773300.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,773.3
119167,,,5162192,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661562,"AUC (0 to infinity) in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1013500.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1013.5
119168,,,5162193,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661561,"AUC (0 to infinity) in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1269200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1269.2
119169,,,5162194,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661560,"AUC (0 to infinity) in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,631800.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,631.8
119170,,,5162195,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661559,"AUC (0 to infinity) in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,858200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,858.2
119171,,,5162196,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661558,"AUC (0 to infinity) in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1038800.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1038.8
119172,,,5162197,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661557,"AUC (0 to infinity) in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1277400.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1277.4
119173,,,5162198,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1661556,"AUC (0 to infinity) in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1082100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1082.1
119174,,,5162199,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1662915,"AUC (0 to infinity) in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,1290500.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,1290.5
119175,,,5162200,[],CHEMBL1662914,"AUC (0 to tau) in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on days 1-3",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,645000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,645.0
119176,,,5162201,[],CHEMBL1662913,"Half life in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.4
119177,,,5162202,[],CHEMBL1662912,"Half life in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.8
119178,,,5162203,[],CHEMBL1662911,"Half life in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,9.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.6
119179,,,5162204,[],CHEMBL1662910,"Half life in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.1
119180,,,5162205,[],CHEMBL1662909,"Half life in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.9
119181,,,5162206,[],CHEMBL1662908,"Half life in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.0
119182,,,5162207,[],CHEMBL1662907,"Half life in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.9
119183,,,5162208,[],CHEMBL1662906,"Half life in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.5
119184,,,5162209,[],CHEMBL1662905,"Half life in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.3
119185,,,5162210,[],CHEMBL1662904,"Half life in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.4
119186,,,5162211,[],CHEMBL1662903,"Half life in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.8
119187,,,5162212,[],CHEMBL1662902,"Half life in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.9
119188,,,5162213,[],CHEMBL1662901,"Half life in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.3
119189,,,5162214,[],CHEMBL1662900,"Half life in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.9
119190,,,5162215,[],CHEMBL1662899,"Half life in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.7
119191,,,5162216,[],CHEMBL1662898,"Half life in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.9
119192,,,5162217,[],CHEMBL1662897,"Half life in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.9
119193,,,5162218,[],CHEMBL1662896,"Half life in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on days 1-3",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,7.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.6
119194,,,5162219,[],CHEMBL1662895,"Clearance in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.16,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.6
119195,,,5162220,[],CHEMBL1662894,"Clearance in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1433,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,8.6
119196,,,5162221,[],CHEMBL1662893,"Clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.12,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.2
119197,,,5162222,[],CHEMBL1662892,"Clearance in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1383,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,8.3
119198,,,5162223,[],CHEMBL1662891,"Clearance in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.135,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,8.1
119199,,,5162224,[],CHEMBL1662890,"Clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1183,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.1
119200,,,5162225,[],CHEMBL1662889,"Clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1233,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.4
119201,,,5162226,[],CHEMBL1662888,"Clearance in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.165,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.9
119202,,,5162227,[],CHEMBL1662887,"Clearance in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1683,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,10.1
119203,,,5162228,[],CHEMBL1662886,"Clearance in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.165,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.9
119204,,,5162229,[],CHEMBL1662885,"Clearance in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1667,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,10.0
119205,,,5162230,[],CHEMBL1662884,"Clearance in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1517,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.1
119206,,,5162231,[],CHEMBL1662883,"Clearance in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.0
119207,,,5162232,[],CHEMBL1662882,"Clearance in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1467,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,8.8
119208,,,5162233,[],CHEMBL1662881,"Clearance in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.0
119209,,,5162234,[],CHEMBL1662880,"Clearance in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.125,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,7.5
119210,,,5162235,[],CHEMBL1662879,"Clearance in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.15,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.0
119211,,,5162236,[],CHEMBL1662878,"Clearance in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on days 1-3",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.1578,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,9.47
119212,,,5162237,[],CHEMBL1662877,"Unbound clearance in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,1.41,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,84.6
119213,,,5162238,[],CHEMBL1662876,"Unbound clearance in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.9917,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,59.5
119214,,,5162239,[],CHEMBL1662875,"Unbound clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.8333,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,50.0
119215,,,5162240,[],CHEMBL1662874,"Unbound clearance in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,1.048,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,62.9
119216,,,5162241,[],CHEMBL1662873,"Unbound clearance in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.9967,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,59.8
119217,,,5162242,[],CHEMBL1662872,"Unbound clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.6817,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,40.9
119218,,,5162243,[],CHEMBL1662871,"Unbound clearance in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.745,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,44.7
119219,,,5162244,[],CHEMBL1662870,"Apparent volume of distribution during terminal phase in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.101,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.101
119220,,,5162245,[],CHEMBL1660543,"Apparent volume of distribution during terminal phase in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.096,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.096
119221,,,5162246,[],CHEMBL1660542,"Apparent volume of distribution during terminal phase in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.099,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.099
119222,,,5162247,[],CHEMBL1660541,"Apparent volume of distribution during terminal phase in healthy human at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.096,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.096
119223,,,5162248,[],CHEMBL1660540,"Apparent volume of distribution during terminal phase in healthy human at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.104,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.104
119224,,,5162249,[],CHEMBL1660539,"Apparent volume of distribution during terminal phase in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.092,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.092
119225,,,5162250,[],CHEMBL1660538,"Apparent volume of distribution during terminal phase in healthy human at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.095,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.095
119226,,,5162251,[],CHEMBL1660537,"Apparent volume of distribution during terminal phase in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1059,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1059
119227,,,5162252,[],CHEMBL1660536,"Apparent volume of distribution during terminal phase in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1029,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1029
119228,,,5162253,[],CHEMBL1660535,"Apparent volume of distribution during terminal phase in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1172,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1172
119229,,,5162254,[],CHEMBL1660534,"Apparent volume of distribution during terminal phase in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1111,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1111
119230,,,5162255,[],CHEMBL1660533,"Apparent volume of distribution during terminal phase in healthy human subjects at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1014,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1014
119231,,,5162256,[],CHEMBL1660532,"Apparent volume of distribution during terminal phase in healthy human subjects at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.1013,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.1013
119232,,,5162257,[],CHEMBL1660531,"Apparent volume of distribution during terminal phase in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.0983,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.0983
119233,,,5162258,[],CHEMBL1655780,"Apparent volume of distribution during terminal phase in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 4",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.0976,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.0976
119234,,,5162259,[],CHEMBL1655781,"Apparent volume of distribution during terminal phase in healthy human subjects at 10 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.0858,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.0858
119235,,,5162260,[],CHEMBL1655782,"Apparent volume of distribution during terminal phase in healthy human subjects at 12 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0003040,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vd,L.kg-1,,0.0992,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vd,L/Kg,UO_0000197,,0.0992
119236,,,5162261,[],CHEMBL1655783,"Unbound fraction in healthy human plasma at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.08,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.08
119237,,,5162262,[],CHEMBL1655784,"Unbound fraction in healthy human plasma at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.07,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.07
119238,,,5162263,[],CHEMBL1655785,"Unbound fraction in healthy human plasma at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 1",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.09,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.09
119239,,,5162264,[],CHEMBL1655786,"Unbound fraction in healthy human plasma at 4 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.08,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.08
119240,,,5162265,[],CHEMBL1655787,"Unbound fraction in healthy human plasma at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.08,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.08
119241,,,5162266,[],CHEMBL1655788,"Unbound fraction in healthy human plasma at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 7",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.09,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.09
119242,,,5162267,[],CHEMBL1655789,"Unbound fraction in healthy human plasma at 8 mg/kg, iv administered as 30 mins infusion every 24 hrs measured on day 14",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Fu,,,0.09,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,,,,0.09
119243,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5162268,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655790,"Cmax in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1325383,=,1,1,=,,Cmax,nM,,30184.67,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,48.92
119244,,,5162269,[],CHEMBL1655791,"Tmax in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0003037,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,Tmax,hr,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,0.6
119245,,,5162270,[],CHEMBL1655792,"Plasma concentration in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs measured after 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,0,=,,Cp,ug ml-1,,5.67,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cp,ug ml-1,UO_0000274,,5.67
119246,,,5162271,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1655793,"AUC ( 0 to infinity) in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,AUC,ng.hr.mL-1,,427310.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,427.31
119247,,,5162272,[],CHEMBL1655794,"Volume of distribution at steady state in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,Vdss,L.kg-1,,0.18,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.18
119248,,,5162273,[],CHEMBL1655795,"Clearance in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1325383,=,1,1,=,,CL,mL.min-1.kg-1,,0.2585,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/hr.Kg,,,15.51
119249,,,5162274,[],CHEMBL1655796,"Half life in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,T1/2,hr,,8.75,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.75
119250,,,5162275,[],CHEMBL1655797,"Mean residence time in cancer patient with neutropenic fever at 6 mg/kg, iv administered as 30 mins infusion every 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1325383,=,1,1,=,,MRT,hr,,11.89,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,11.89
119251,,,5162276,[],CHEMBL1655798,Plasma protein binding in human after 0.5 hrs,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,1,=,,PPB,%,,94.2,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,94.2
119252,,,5162277,[],CHEMBL1655799,Plasma protein binding in human after 2 hrs,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,1,=,,PPB,%,,93.7,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,93.7
119253,,,5162278,[],CHEMBL1655800,Plasma protein binding in human after 8 hrs,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1325383,=,1,1,=,,PPB,%,,93.2,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,93.2
119254,,,5162279,[],CHEMBL1655801,Antimicrobial activity against Staphylococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,<,1,1,<,,MIC90,ug.mL-1,,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119255,,,5162280,[],CHEMBL1655802,Antimicrobial activity against Enterococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649119,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325383,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119256,,,5162639,[],CHEMBL1666797,Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.75
119257,,,5162640,[],CHEMBL1666798,Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus H14 harboring vraS S329L mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,1.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.75
119258,,,5162641,[],CHEMBL1666799,"Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus deltaIP-KVR by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119259,,,5162642,[],CHEMBL1666800,"Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus H14-KVR by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119260,,,5162643,[],CHEMBL1666801,Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR harboring RpoB H481Y mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119261,,,5162644,[],CHEMBL1666802,Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP::vraSH14 harboring vraSH14 S329L mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,1.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.75
119262,,,5162645,[],CHEMBL1666803,Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR::vraSH14 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,2.0
119263,,,5162646,[],CHEMBL1666804,Antibacterial activity against hetero-vancomycin-intermediate Staphylococcus aureus Mu3 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649526,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327001,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,2.0
119264,,,5162655,[],CHEMBL1667637,Aqueous diffusion coefficient of Bodipy-tagged compound at 23 degC by time lapse confocal scanning microscopy,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1327003,=,1,0,=,,D,10'-6cm2/s,,1.73,CHEMBL2362975,,No relevant target,,,,D,10'-6cm2/s,,,1.73
119265,,,5162656,[],CHEMBL1667638,Aqueous diffusion coefficient of rhodamine-tagged compound at 23 degC by time lapse confocal scanning microscopy,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1327003,=,1,0,=,,D,10'-6cm2/s,,1.78,CHEMBL2362975,,No relevant target,,,,D,10'-6cm2/s,,,1.78
119266,,,5162657,[],CHEMBL1666805,Permeability of Bodipy-tagged compound across Staphylococcus epidermidis RP62A biofilms assessed as diffusion coefficient at 23 degC by time lapse confocal scanning microscopy,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1327003,=,1,0,=,,D,10'-7cm2/sec,,5.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,D,10'-7cm2/sec,,,5.2
119267,,,5162658,[],CHEMBL1666806,Permeability of rhodamine-tagged compound across Staphylococcus epidermidis RP62A biofilms assessed as diffusion coefficient at 23 degC by time lapse confocal scanning microscopy,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1327003,=,1,0,=,,D,10'-7cm2/sec,,4.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,D,10'-7cm2/sec,,,4.7
119268,,,5162659,[],CHEMBL1666807,Permeability of unlabeled compound across Staphylococcus epidermidis RP62A biofilms assessed as diffusion coefficient at 23 degC by time lapse confocal scanning microscop,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1327003,=,1,0,=,,D,10'-6cm2/s,,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,D,10'-6cm2/s,,,0.78
119269,,,5162660,[],CHEMBL1666808,Permeability of Bodipy-tagged compound across Staphylococcus epidermidis RP62A biofilms with 181 micrometer radial dimensions and 103 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.01861,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,67.0
119270,,,5162661,[],CHEMBL1666809,Permeability of Bodipy-tagged compound across Staphylococcus epidermidis RP62A biofilms with 278 micrometer radial dimensions and 168 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.05833,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,210.0
119271,,,5162662,[],CHEMBL1667633,Permeability of Bodipy-tagged compound across Staphylococcus epidermidis RP62A biofilms with 223 micrometer radial dimensions and 153 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.01667,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,60.0
119272,,,5162663,[],CHEMBL1667634,Permeability of rhodamine-tagged compound across Staphylococcus epidermidis RP62A biofilms with 217 micrometer radial dimensions and 115 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.03889,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,140.0
119273,,,5162664,[],CHEMBL1667635,Permeability of rhodamine-tagged compound across Staphylococcus epidermidis RP62A biofilms with 207 micrometer radial dimensions and 97 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.01111,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,40.0
119274,,,5162665,[],CHEMBL1667636,Permeability of rhodamine-tagged compound across Staphylococcus epidermidis RP62A biofilms with 94 micrometer radial dimensions and 63 micrometer orthogonal dimensions assessed as time required for fluorescence intensity in centre of biofilm cluster to reach 50% of steady state maximum bulk fluid fluorescence intensity,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649527,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1327003,=,1,1,=,,TIME,hr,,0.007222,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,s,UO_0000032,,26.0
119275,,,5165450,[],CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119276,,,5165459,[],CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119277,,,5165468,[],CHEMBL1653954,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119278,,,5165477,[],CHEMBL1653956,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119279,,,5165486,[],CHEMBL1653958,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,96.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,96.0
119280,,,5165495,[],CHEMBL1653960,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,71.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,71.0
119281,,,5165504,[],CHEMBL1653962,Antimicrobial activity against Coagulase-negative Staphylococcus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,Activity,%,UO_0000187,,100.0
119282,,,5165513,[],CHEMBL1653964,Antimicrobial activity against Group A Streptococcus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,Activity,%,UO_0000187,,100.0
119283,,,5165522,[],CHEMBL1653966,Antimicrobial activity against Group B Streptococcus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,Activity,%,UO_0000187,,100.0
119284,,,5165531,[],CHEMBL1653968,Antimicrobial activity against Group C Streptococcus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
119285,,,5165540,[],CHEMBL1653970,Antimicrobial activity against Group G Streptococcus assessed as susceptible isolates by agar dilution method,F,,,BAO_0001103,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322879,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
119286,,Not Determined,5165549,[],CHEMBL1653972,Antimicrobial activity against Streptococcus pneumoniae assessed as susceptible isolates by agar dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322879,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
119287,,Not Determined,5165558,[],CHEMBL1653974,Antimicrobial activity against Corynebacterium spp. assessed as susceptible isolates by agar dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322879,,1,0,,,Activity,,,,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,Activity,,,,
119288,,Not Determined,5165567,[],CHEMBL1653976,Antimicrobial activity against Listeria monocytogenes assessed as susceptible isolates by agar dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322879,,1,0,,,Activity,,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,Activity,,,,
119289,,,5175241,[],CHEMBL1654788,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
119290,,,5175242,[],CHEMBL1654789,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 post isolation by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
119291,,,5175243,[],CHEMBL1654870,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation stratified with vancomycin MIC < 1.5 mh/L by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC50,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.38
119292,,,5175244,[],CHEMBL1654788,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC90,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.75
119293,,,5175245,[],CHEMBL1654789,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 post isolation by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,1.0
119294,,,5175246,[],CHEMBL1654870,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation stratified with vancomycin MIC < 1.5 mh/L by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC90,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.75
119295,,,5175247,[],CHEMBL1654788,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.13
119296,,,5175248,[],CHEMBL1654789,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 post isolation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.19
119297,,,5175249,[],CHEMBL1654870,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolated form patient blood measured after 18 to 24 hrs on day 1 isolation stratified with vancomycin MIC < 1.5 mh/L by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649298,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323367,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.13
119298,,,5175971,[],CHEMBL1665478,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
119299,,,5175972,[],CHEMBL1665479,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as intermediate isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
119300,,,5175981,[],CHEMBL1665488,Antimicrobial activity against heterogeneous vancomycin-susceptible Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
119301,,,5175982,[],CHEMBL1665489,Antimicrobial activity against heterogeneous vancomycin-susceptible Staphylococcus aureus assessed as intermediate isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
119302,,,5175984,[],CHEMBL1665482,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.125 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
119303,,,5176042,[],CHEMBL1666931,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
119304,,,5176043,[],CHEMBL1666932,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
119305,,,5176044,[],CHEMBL1666937,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
119306,,,5176045,[],CHEMBL1666938,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
119307,,,5176046,[],CHEMBL1665472,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
119308,,,5176048,[],CHEMBL1665474,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119309,,,5176049,[],CHEMBL1665484,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
119310,,,5176050,[],CHEMBL1665484,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.5
119311,,,5176068,[],CHEMBL1666926,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119312,,,5176069,[],CHEMBL1666927,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119313,,,5176070,[],CHEMBL1666928,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119314,,,5176071,[],CHEMBL1666929,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119315,,,5176072,[],CHEMBL1666930,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119316,,,5176073,[],CHEMBL1666933,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119317,,,5176074,[],CHEMBL1666934,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119318,,,5176075,[],CHEMBL1666935,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119319,,,5176076,[],CHEMBL1666936,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119320,,,5176077,[],CHEMBL1666939,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119321,,,5176078,[],CHEMBL1666940,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119322,,,5176079,[],CHEMBL1666941,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119323,,,5176080,[],CHEMBL1666944,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119324,,,5176081,[],CHEMBL1666945,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119325,,,5176082,[],CHEMBL1666946,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119326,,,5176083,[],CHEMBL1666947,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119327,,,5176084,[],CHEMBL1667421,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119328,,,5176085,[],CHEMBL1667423,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119329,,,5176086,[],CHEMBL1667424,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119330,,,5176087,[],CHEMBL1667425,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
119331,,,5176088,[],CHEMBL1665496,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.125 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,0.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.58
119332,,,5176092,[],CHEMBL1665472,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,1.0
119333,,,5176141,[],CHEMBL1666942,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
119334,,,5176142,[],CHEMBL1666943,Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
119335,,,5176143,[],CHEMBL1667422,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
119336,,,5176194,[],CHEMBL1665497,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.25 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,10.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,10.7
119337,,,5176196,[],CHEMBL1665481,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.25 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,14.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,14.8
119338,,,5176254,[],CHEMBL1665491,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 0.5 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,88.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,88.9
119339,,,5176257,[],CHEMBL1665498,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 0.5 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,95.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,95.1
119340,,,5176265,[],CHEMBL1665480,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119341,,,5176270,[],CHEMBL1665490,Antimicrobial activity against heterogeneous vancomycin-susceptible Staphylococcus aureus assessed as susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119342,,,5176272,[],CHEMBL1665492,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119343,,,5176274,[],CHEMBL1665493,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 2 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119344,,,5176278,[],CHEMBL1665494,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 4 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119345,,,5176283,[],CHEMBL1665495,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus assessed as growth inhibition at 16 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119346,,,5176288,[],CHEMBL1665499,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119347,,,5177298,[],CHEMBL1665500,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 2 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119348,,,5177303,[],CHEMBL1665501,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 4 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119349,,,5177308,[],CHEMBL1665529,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus assessed as growth inhibition at 16 times MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1321864,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119350,,,5177395,[],CHEMBL1665484,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
119351,,,5177397,[],CHEMBL1665472,Antimicrobial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321864,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
119352,,,5181371,[],CHEMBL1667111,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus MED2034,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327108,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
119353,,,5181935,[],CHEMBL1660400,Antimicrobial activity against Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
119354,,,5181944,[],CHEMBL1660399,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
119355,,,5181951,[],CHEMBL1660398,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
119356,,,5181958,[],CHEMBL1660397,Antimicrobial activity against Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
119357,,,5181965,[],CHEMBL1660396,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
119358,,,5181972,[],CHEMBL1660395,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
119359,,,5181979,[],CHEMBL1660394,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.03
119360,,,5181986,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.12
119361,,,5181994,[],CHEMBL1660392,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.03
119362,,,5182000,[],CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.06
119363,,,5182007,[],CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.06
119364,,,5182014,[],CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
119365,,,5182021,[],CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
119366,,,5182029,[],CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
119367,,,5182037,[],CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
119368,,,5182045,[],CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
119369,,,5182053,[],CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
119370,,,5182061,[],CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
119371,,,5182069,[],CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.25
119372,,,5183246,[],CHEMBL1660400,Antimicrobial activity against Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119373,,,5183253,[],CHEMBL1660399,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119374,,,5183260,[],CHEMBL1660398,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119375,,,5183267,[],CHEMBL1660397,Antimicrobial activity against Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119376,,,5183274,[],CHEMBL1660396,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119377,,,5183281,[],CHEMBL1660395,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119378,,,5183288,[],CHEMBL1660394,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119379,,,5183295,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119380,,,5183303,[],CHEMBL1660392,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119381,,,5183309,[],CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119382,,,5183316,[],CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119383,,,5183323,[],CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119384,,,5183330,[],CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119385,,,5183338,[],CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119386,,,5183346,[],CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119387,,,5183354,[],CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119388,,,5183362,[],CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119389,,,5183370,[],CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119390,,,5183378,[],CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322861,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119391,,,5183495,[],CHEMBL1652915,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,93.1,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,93.1
119392,,,5183502,[],CHEMBL1652916,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,98.8
119393,,,5183509,[],CHEMBL1653016,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,98.5
119394,,,5183516,[],CHEMBL1653017,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,98.3
119395,,,5183523,[],CHEMBL1653018,Antimicrobial activity against Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.4,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,98.4
119396,,,5183530,[],CHEMBL1653019,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
119397,,,5183537,[],CHEMBL1653020,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,98.5
119398,,,5183544,[],CHEMBL1653021,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,98.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,98.9
119399,,,5183551,[],CHEMBL1653022,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,99.9
119400,,,5183558,[],CHEMBL1653023,Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,99.9
119401,,,5183566,[],CHEMBL1653024,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,100.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,100.0
119402,,,5183572,[],CHEMBL1653025,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,100.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,100.0
119403,,,5183579,[],CHEMBL1653026,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,100.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,100.0
119404,,,5183614,[],CHEMBL1664256,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
119405,,,5183615,[],CHEMBL1664257,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK2 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119406,,,5183616,[],CHEMBL1664258,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK3 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119407,,,5183617,[],CHEMBL1664259,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK4 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.38
119408,,,5183618,[],CHEMBL1664260,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK5 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.75
119409,,,5183619,[],CHEMBL1664261,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK6 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
119410,,,5183620,[],CHEMBL1664262,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK7 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
119411,,,5183621,[],CHEMBL1664263,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CGK8 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649320,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323780,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
119412,,,5184865,[],CHEMBL1653027,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,99.8
119413,,,5184871,[],CHEMBL1653028,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
119414,,,5184877,[],CHEMBL1653029,Antimicrobial activity against Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,99.9
119415,,,5184883,[],CHEMBL1653030,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
119416,,,5184889,[],CHEMBL1653031,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
119417,,,5184895,[],CHEMBL1653032,Antimicrobial activity against Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322861,=,1,0,=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
119418,,,5185921,[],CHEMBL1660127,Antimicrobial activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 by M7-A6 method in presence of 50 mg/L calcium ions,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
119419,,,5185922,[],CHEMBL1660289,Antimicrobial activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 selected on 1 to 5 ug/ml of compound measured after 5 days by M7-A6 method in presence of 50 mg/L calcium ions,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
119420,,,5185929,[],CHEMBL1660130,Bactericidal activity against stationary-phase methicillin-resistant Staphylococcus aureus HUSA 304 after 24 hrs by time kill analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,0,=,,MBC,ug ml-1,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,24.0
119421,,,5185930,[],CHEMBL1660128,Bactericidal activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 after 24 hrs by time kill analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,4.0
119422,,,5185937,[],CHEMBL1660282,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus HUSA 304 infected in Wistar rat assessed as decrease in bacterial load in tissue cage fluid at 100 mg/kg/day, ip administered for 7 days measured on day 11 post treatment in presence of 50 mg/L calcium ions",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,log10cfu,,,2.57,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.57
119423,,,5185938,[],CHEMBL1660281,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus HUSA 304 infected in Wistar rat assessed as decrease in bacterial load in tissue cage fluid at 100 mg/kg/day, ip administered for 7 days measured on day 8 post treatment in presence of 50 mg/L calcium ions",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,log10cfu,,,2.26,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.26
119424,,,5185939,[],CHEMBL1660137,"Cmin in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip determined on day 4",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,0,=,,Cmin,ug ml-1,,18.0,CHEMBL612558,,ADMET,,,,Cmin,ug ml-1,UO_0000274,,18.0
119425,,,5185940,[],CHEMBL1660136,"Cmin in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip determined on day 4",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,0,=,,Cmin,ug ml-1,,16.0,CHEMBL612558,,ADMET,,,,Cmin,ug ml-1,UO_0000274,,16.0
119426,,,5185941,[],CHEMBL1660135,"Cmin in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip determined on day 4",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322352,=,1,0,=,,Cmin,ug ml-1,,10.0,CHEMBL612558,,ADMET,,,,Cmin,ug ml-1,UO_0000274,,10.0
119427,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185942,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660274,"Cmax in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 10 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,80212.75,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Cmax,ug ml-1,UO_0000065,,130.0
119428,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185943,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660273,"Cmax in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 8 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,65404.24,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Cmax,ug ml-1,UO_0000065,,106.0
119429,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185944,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660272,"Cmax in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 6 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,58617.01,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Cmax,ug ml-1,UO_0000065,,95.0
119430,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185945,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660271,"Cmax in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,86382.96,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,Cmax,ug ml-1,UO_0000065,,140.0
119431,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185946,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '70.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '70.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660270,"Cmax in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,78978.71,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,Cmax,ug ml-1,UO_0000065,,128.0
119432,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185947,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660269,"Cmax in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip for 7 days",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,63553.18,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,Cmax,ug ml-1,UO_0000065,,103.0
119433,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185948,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660134,"Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,24680.85,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,40.0
119434,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185949,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '70.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '70.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660133,"Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,20978.72,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,34.0
119435,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5185950,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1660132,"Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/Nanomolar,1322352,=,1,1,=,,Cmax,nM,,16042.55,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,26.0
119436,,,5185951,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1660280,"AUC (0 to 24 hrs) in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 10 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,1013000.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,AUC,ug.hr/ml,,,1013.0
119437,,,5185952,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '8.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1660279,"AUC (0 to 24 hrs) in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 8 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,773000.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,AUC,ug.hr/ml,,,773.0
119438,,,5185953,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '6.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1660278,"AUC (0 to 24 hrs) in serum of human infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 6 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,730000.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,AUC,ug.hr/ml,,,730.0
119439,,,5185954,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660277,"AUC (0 to infinity) in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,1200000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,AUC,ug.hr/ml,,,1200.0
119440,,,5185955,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '70.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '70.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660276,"AUC (0 to infinity) in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,984000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,AUC,ug.hr/ml,,,984.0
119441,,,5185956,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660275,"AUC (0 to infinity) in serum of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip for 7 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,830000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,AUC,ug.hr/ml,,,830.0
119442,,,5185957,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660259,"AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,1100000.0,CHEMBL612558,,ADMET,,,,AUC,ug.hr/ml,,,1100.0
119443,,,5185958,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '70.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '70.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660139,"AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,953000.0,CHEMBL612558,,ADMET,,,,AUC,ug.hr/ml,,,953.0
119444,,,5185959,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1660138,"AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,1,=,,AUC,ng.hr.mL-1,,795000.0,CHEMBL612558,,ADMET,,,,AUC,ug.hr/ml,,,795.0
119445,,Active,5185963,[],CHEMBL1658522,Antimicrobial activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 assessed as resistant bacteria on coverslip selected on 1 to 5 ug/ml of compound measured on day 11 post treatment in presence of 50 mg/L calcium ions,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
119446,,Active,5185964,[],CHEMBL1658519,Antimicrobial activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 assessed as resistant bacteria in tissue cage fluid selected on 1 to 5 ug/ml of compound measured on day 11 post treatment in presence of 50 mg/L calcium ions,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
119447,,Active,5185965,[],CHEMBL1660290,Antimicrobial activity against log-phase methicillin-resistant Staphylococcus aureus HUSA 304 assessed as resistant bacteria in tissue cage fluid selected on 1 to 5 ug/ml of compound measured on day 8 post treatment in presence of 50 mg/L calcium ions,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
119448,,,5185966,[],CHEMBL1660260,"Ratio of Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,Ratio,,,26.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,26.0
119449,,,5185967,[],CHEMBL1660261,"Ratio of Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,Ratio,,,34.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,34.0
119450,,,5185968,[],CHEMBL1660262,"Ratio of Cmax in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,Ratio,,,40.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,40.0
119451,,,5185969,[],CHEMBL1660263,"Ratio of AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 45 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,RatioAUC/MIC,,,795.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,795.0
119452,,,5185970,[],CHEMBL1660264,"Ratio of AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 70 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,RatioAUC/MIC,,,953.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,953.0
119453,,,5185971,[],CHEMBL1660265,"Ratio of AUC (0 to infinity) in tissue cage fluid of Wistar rat infected with methicillin-resistant Staphylococcus aureus HUSA 304 at 100 mg/kg/day, ip to MIC for methicillin-resistant Staphylococcus aureus HUSA 304",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1322352,=,1,0,=,,RatioAUC/MIC,,,1100.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,1100.0
119454,,,5185972,[],CHEMBL1660266,"fT>MIC in methicillin-resistant Staphylococcus aureus HU 304 infected in Wistar rat at 45 mg/kg/day, ip for 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322352,=,1,0,=,,fT>MIC,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,100.0
119455,,,5185973,[],CHEMBL1660267,"fT>MIC in methicillin-resistant Staphylococcus aureus HU 304 infected in Wistar rat at 70 mg/kg/day, ip for 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322352,=,1,0,=,,fT>MIC,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,100.0
119456,,,5185974,[],CHEMBL1660268,"fT>MIC in methicillin-resistant Staphylococcus aureus HU 304 infected in Wistar rat at 100 mg/kg/day, ip for 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649229,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1322352,=,1,0,=,,fT>MIC,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,100.0
119457,,,5186022,[],CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119458,,,5186031,[],CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119459,,,5186040,[],CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119460,,,5186049,[],CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119461,,,5186058,[],CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
119462,,,5186067,[],CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC,ug ml-1,UO_0000274,,0.015
119463,,,5186076,[],CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.015
119464,,,5186085,[],CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
119465,,,5186094,[],CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
119466,,,5186103,[],CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
119467,,,5186112,[],CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,MIC,ug ml-1,UO_0000274,,0.03
119468,,,5186121,[],CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,0.5
119469,,,5186130,[],CHEMBL1653977,Antimicrobial activity against Streptococcus mitis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.006
119470,,,5186139,[],CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119471,,,5186148,[],CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
119472,,,5186157,[],CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119473,,,5186166,[],CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119474,,,5186175,[],CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119475,,,5186184,[],CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC50,ug ml-1,UO_0000274,,0.015
119476,,,5186193,[],CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC50,ug ml-1,UO_0000274,,0.015
119477,,,5186202,[],CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.03
119478,,,5186211,[],CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
119479,,,5186220,[],CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119480,,,5186229,[],CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119481,,,5186238,[],CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119482,,,5186247,[],CHEMBL1653977,Antimicrobial activity against Streptococcus mitis by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119483,,,5186256,[],CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119484,,,5186265,[],CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119485,,,5186274,[],CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119486,,,5186283,[],CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119487,,,5186292,[],CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119488,,,5186301,[],CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC90,ug ml-1,UO_0000274,,0.03
119489,,,5186310,[],CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC90,ug ml-1,UO_0000274,,0.06
119490,,,5186319,[],CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.12
119491,,,5186328,[],CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.03
119492,,,5186337,[],CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322879,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119493,,,5210640,[],CHEMBL1677617,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 100 mg/litre at ambient temperature of 35 degC after 24 hrs relative to baseline,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332596,=,1,0,=,,FC,,,2.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,FC,,,,2.0
119494,,,5210641,[],CHEMBL1677618,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 25 mg/litre at ambient temperature of 45 degC after 24 hrs relative to baseline,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332596,=,1,0,=,,FC,,,1.2,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,FC,,,,1.2
119495,,,5210642,[],CHEMBL1677619,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 100 mg/litre at ambient temperature of 40 degC after 24 hrs relative to baseline,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332596,=,1,0,=,,FC,,,3.6,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,FC,,,,3.6
119496,,,5210643,[],CHEMBL1677620,Antimicrobial activity against Staphylococcus isolates biofilms assessed as decrease in bacterial load at 100 mg/litre at ambient temperature of 45 degC after 24 hrs relative to baseline,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332596,=,1,0,=,,FC,,,3.3,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,FC,,,,3.3
119497,,,5210703,[],CHEMBL1677496,Antimicrobial activity against Staphylococcus aureus isolated from human prosthetic joint infection site by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.125
119498,,,5210704,[],CHEMBL1677497,Antimicrobial activity against coagulase-negative Staphylococcus isolated from human prosthetic joint infection site by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug/L,UO_0000274,,0.125
119499,,,5210705,[],CHEMBL1677495,Antimicrobial activity against Staphylococcus aureus isolated from human preoperative skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.125
119500,,,5210706,[],CHEMBL1677494,Antimicrobial activity against coagulase-negative Staphylococcus isolated from human preoperative skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.00025,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug/L,UO_0000274,,0.25
119501,,,5210707,[],CHEMBL1677493,Antimicrobial activity against Staphylococcus epidermidis isolate KO8 isolated from healthy human skin by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.00025,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,0.25
119502,,,5210708,[],CHEMBL1677492,Antimicrobial activity against Staphylococcus aureus ATCC 29213 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.125
119503,,,5210709,[],CHEMBL1677490,Antimicrobial activity against Staphylococcus epidermidis DSM3269 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.00025,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,0.25
119504,,,5210714,[],CHEMBL1677491,Antimicrobial activity against Staphylococcus aureus ATCC 29213 administered as powder at 45 degC after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug/L,UO_0000274,,0.5
119505,,,5210719,[],CHEMBL1677498,Antimicrobial activity against Staphylococcus epidermidis isolate OR1 treated in solution at 45 degC after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671740,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332596,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug/L,UO_0000274,,1.0
119506,,,5212078,[],CHEMBL1678623,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus SH1000 assessed as inhibition of bacterial biofilm formation by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332643,=,1,0,=,,MBIC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,2.0
119507,,,5212083,[],CHEMBL1678622,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial biofilm formation by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332643,=,1,0,=,,MBIC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,2.0
119508,,,5212088,[],CHEMBL1678630,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus SH1000 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332643,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
119509,,,5212093,[],CHEMBL1678631,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332643,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
119510,,,5212098,[],CHEMBL1678621,fCmax in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg every 24 hrs,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332643,=,1,0,=,,fCmax,ug ml-1,,11.79,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fCmax,ug ml-1,UO_0000274,,11.79
119511,,,5212099,[],CHEMBL1678620,Half life in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg every 24 hrs,A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Hour,1332643,=,1,1,=,,T1/2,hr,,8.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,t1/2,hr,UO_0000032,,8.21
119512,,,5212100,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1678619,AUC (0 to 24 hrs) in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg every 24 hrs,A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,=,1,1,=,,AUC,ng.hr.mL-1,,199770.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,AUC,ug/ml.hr,,,199.77
119513,,Active,5212113,[],CHEMBL1678633,Bactericidal activity against methicillin-resistant Staphylococcus aureus N315 planktonic cell in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in bacterial count at 10 mg/kg every 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
119514,,Not Active,5212114,[],CHEMBL1678632,Bactericidal activity against methicillin-resistant Staphylococcus aureus N315 in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in planktonic cell count at 10 mg/kg every 24 hrs measured after 48 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
119515,,,5212115,[],CHEMBL1678640,Bactericidal activity against methicillin-resistant Staphylococcus aureus N315 planktonic cell in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in bacterial count at 10 mg/kg every 24 hrs measured after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,=,1,0,=,,log10CFU/ml,,,2.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.78
119516,,,5212116,[],CHEMBL1678641,Bactericidal activity against methicillin-resistant Staphylococcus aureus N315 in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in biofilm bacterial count at 10 mg/kg every 24 hrs measured after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,=,1,0,=,,log10CFU/ml,,,2.73,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.73
119517,,,5212117,[],CHEMBL1678638,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in planktonic cell count at 10 mg/kg every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,=,1,0,=,,log10CFU/ml,,,2.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.2
119518,,,5212118,[],CHEMBL1678639,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in biofilm bacterial count at 10 mg/kg every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1332643,=,1,0,=,,log10CFU/ml,,,2.83,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.83
119519,,,5214016,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119520,,,5214026,[],CHEMBL1674080,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,99.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.4
119521,,,5214045,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119522,,,5214055,[],CHEMBL1674083,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,99.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.2
119523,,,5214074,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119524,,,5214084,[],CHEMBL1674200,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
119525,,,5214297,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,4.0
119526,,,5214303,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119527,,,5214309,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119528,,,5214315,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119529,,,5214321,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC50,ug ml-1,UO_0000274,,8.0
119530,,,5214327,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119531,,,5214333,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC50,ug ml-1,UO_0000274,,64.0
119532,,,5214339,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119533,,,5214345,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119534,,,5214351,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119535,,,5214357,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119536,,,5214363,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119537,,,5214369,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119538,,,5214375,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119539,,,5214381,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119540,,,5214387,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119541,,,5214393,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119542,,,5214399,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119543,,,5214405,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119544,,,5214411,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119545,,,5214417,[],CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119546,,,5214423,[],CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119547,,,5214429,[],CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119548,,,5214435,[],CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119549,,,5215137,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119550,,,5215147,[],CHEMBL1674203,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,99.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.7
119551,,,5215166,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119552,,,5215185,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119553,,,5215204,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
119554,,,5215212,[],CHEMBL1674212,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
119555,,,5215223,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
119556,,,5215231,[],CHEMBL1674215,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
119557,,,5215240,[],CHEMBL1674217,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
119558,,,5215249,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.12
119559,,,5215258,[],CHEMBL1674220,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
119560,,,5215267,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.12
119561,,,5215279,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119562,,,5215287,[],CHEMBL1674224,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,100.0
119563,,,5215301,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119564,,,5215309,[],CHEMBL1674227,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,100.0
119565,,,5215316,[],CHEMBL1674228,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,0.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,0.0
119566,,,5215324,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119567,,,5215332,[],CHEMBL1674230,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
119568,,,5215338,[],CHEMBL1674231,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
119569,,,5215347,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119570,,,5215355,[],CHEMBL1674233,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
119571,,,5215361,[],CHEMBL1674234,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
119572,,,5215370,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119573,,,5215378,[],CHEMBL1674236,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,100.0
119574,,,5215384,[],CHEMBL1674237,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1331819,=,1,0,=,,Activity,%,,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.0
119575,,,5215476,[],CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119576,,,5215482,[],CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119577,,,5215514,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,4.0
119578,,,5215520,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119579,,,5215526,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119580,,,5215532,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119581,,,5215538,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC90,ug ml-1,UO_0000274,,16.0
119582,,,5215544,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119583,,,5215550,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC90,ug ml-1,UO_0000274,,64.0
119584,,,5215556,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119585,,,5215562,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119586,,,5215568,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119587,,,5215574,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119588,,,5215580,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119589,,,5215586,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119590,,,5215592,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119591,,,5215598,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119592,,,5215604,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119593,,,5215610,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119594,,,5215616,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119595,,,5215622,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119596,,,5215628,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119597,,,5215634,[],CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119598,,,5215640,[],CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119599,,,5215646,[],CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119600,,,5215652,[],CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119601,,,5215658,[],CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC90,ug ml-1,UO_0000274,,8.0
119602,,,5215664,[],CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
119603,,,5215696,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
119604,,,5215702,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC,ug ml-1,UO_0000274,,0.5
119605,,,5215708,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.25
119606,,,5215714,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119607,,,5215720,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC,ug ml-1,UO_0000274,,4.0
119608,,,5215726,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.25
119609,,,5215732,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC,ug ml-1,UO_0000274,,16.0
119610,,,5215738,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
119611,,,5215744,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119612,,,5215750,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC,ug ml-1,UO_0000274,,0.12
119613,,,5215756,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC,ug ml-1,UO_0000274,,0.12
119614,,,5215762,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC,ug ml-1,UO_0000274,,0.12
119615,,,5215768,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119616,,,5215774,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119617,,,5215780,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119618,,,5215786,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119619,,,5215792,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119620,,,5215798,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119621,,,5215804,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC,ug ml-1,UO_0000274,,0.12
119622,,,5215810,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119623,,,5216850,[],CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC,ug ml-1,UO_0000274,,0.12
119624,,,5216856,[],CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119625,,,5216862,[],CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC,ug ml-1,UO_0000274,,0.12
119626,,,5216868,[],CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119627,,,5216874,[],CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC,ug ml-1,UO_0000274,,0.12
119628,,,5216880,[],CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119629,,,5216912,[],CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119630,,,5216918,[],CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119631,,,5216924,[],CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119632,,,5216930,[],CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119633,,,5216936,[],CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119634,,,5216942,[],CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119635,,,5216948,[],CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119636,,,5216954,[],CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119637,,,5216960,[],CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119638,,,5216966,[],CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119639,,,5216972,[],CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119640,,,5216978,[],CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119641,,,5216984,[],CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119642,,,5216990,[],CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119643,,,5216996,[],CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119644,,,5217002,[],CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
119645,,,5217008,[],CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
119646,,,5217014,[],CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119647,,,5217020,[],CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119648,,,5217026,[],CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119649,,,5217032,[],CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119650,,,5217038,[],CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119651,,,5217044,[],CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
119652,,,5217050,[],CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119653,,,5217056,[],CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119654,,,5217062,[],CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119655,,,5217068,[],CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119656,,,5217074,[],CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119657,,,5217080,[],CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119658,,,5217086,[],CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119659,,,5217092,[],CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
119660,,,5217098,[],CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119661,,,5217104,[],CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119662,,,5217110,[],CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119663,,,5217116,[],CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119664,,,5217122,[],CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119665,,,5217163,[],CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119666,,,5217169,[],CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119667,,,5217175,[],CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119668,,,5217912,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119669,,,5217923,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119670,,,5217934,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119671,,,5217945,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119672,,,5217956,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119673,,,5217967,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119674,,,5217978,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119675,,,5217989,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119676,,,5218000,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119677,,,5218009,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
119678,,,5218018,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119679,,,5218027,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
119680,,,5218036,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
119681,,,5218046,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
119682,,,5218056,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119683,,,5218066,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
119684,,,5218076,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119685,,,5218086,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.03
119686,,,5218096,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119687,,,5218106,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.06
119688,,,5218116,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119689,,,5218126,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.03
119690,,,5218136,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119691,,,5218146,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.12
119692,,,5218156,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119693,,,5218167,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
119694,,,5218178,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119695,,,5218189,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
119696,,,5218200,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119697,,,5218211,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331819,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.5
119698,,,5218218,[],CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119699,,,5218224,[],CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119700,,,5218230,[],CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119701,,,5218236,[],CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119702,,,5218242,[],CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119703,,,5218248,[],CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119704,,,5218254,[],CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119705,,,5218260,[],CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119706,,,5218266,[],CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119707,,,5218272,[],CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC90,ug ml-1,UO_0000274,,32.0
119708,,,5218278,[],CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119709,,,5218284,[],CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
119710,,,5218290,[],CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
119711,,,5218296,[],CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
119712,,,5218302,[],CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119713,,,5218308,[],CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119714,,,5218314,[],CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119715,,,5218320,[],CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119716,,,5218326,[],CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119717,,,5218332,[],CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
119718,,,5218338,[],CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119719,,,5218344,[],CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119720,,,5218350,[],CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119721,,,5218356,[],CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119722,,,5218362,[],CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119723,,,5218368,[],CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119724,,,5218374,[],CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119725,,,5218380,[],CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,4.0
119726,,,5218386,[],CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119727,,,5218392,[],CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119728,,,5218398,[],CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119729,,,5218404,[],CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119730,,,5218410,[],CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119731,,,5218451,[],CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,,MIC,ug ml-1,UO_0000274,,0.12
119732,,,5218457,[],CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119733,,,5218463,[],CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,,MIC,ug ml-1,UO_0000274,,0.12
119734,,,5218469,[],CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,,MIC,ug ml-1,UO_0000274,,0.12
119735,,,5218475,[],CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119736,,,5218481,[],CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119737,,,5218487,[],CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,,MIC,ug ml-1,UO_0000274,,0.12
119738,,,5218493,[],CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119739,,,5218499,[],CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119740,,,5218505,[],CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,,MIC,ug ml-1,UO_0000274,,0.12
119741,,,5218511,[],CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119742,,,5218517,[],CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119743,,,5218523,[],CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC,ug ml-1,UO_0000274,,0.12
119744,,,5218529,[],CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119745,,,5218535,[],CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119746,,,5218541,[],CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119747,,,5218547,[],CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119748,,,5219608,[],CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119749,,,5219614,[],CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119750,,,5219620,[],CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119751,,,5219626,[],CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119752,,,5219632,[],CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119753,,,5219638,[],CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
119754,,,5219644,[],CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,,MIC,ug ml-1,UO_0000274,,0.12
119755,,,5219650,[],CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC,ug ml-1,UO_0000274,,0.12
119756,,,5219656,[],CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,,MIC,ug ml-1,UO_0000274,,0.12
119757,,,5219662,[],CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,0.12
119758,,,5219668,[],CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.12
119759,,,5219674,[],CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,0.12
119760,,,5219680,[],CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC,ug ml-1,UO_0000274,,0.12
119761,,,5219686,[],CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
119762,,,5219692,[],CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,1.0
119763,,,5219698,[],CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,1.0
119764,,,5219704,[],CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,128.0
119765,,,5219710,[],CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC,ug ml-1,UO_0000274,,128.0
119766,,,5219716,[],CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,128.0
119767,,,5219757,[],CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119768,,,5219763,[],CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119769,,,5219769,[],CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119770,,,5219775,[],CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,128.0
119771,,,5219781,[],CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,128.0
119772,,,5219787,[],CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119773,,,5219793,[],CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119774,,,5219799,[],CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119775,,,5219805,[],CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119776,,,5219811,[],CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119777,,,5219817,[],CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119778,,,5219823,[],CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119779,,,5219829,[],CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119780,,,5219835,[],CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119781,,,5219841,[],CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119782,,,5219847,[],CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119783,,,5219853,[],CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119784,,,5219859,[],CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,,MIC50,ug ml-1,UO_0000274,,128.0
119785,,,5219865,[],CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,128.0
119786,,,5219871,[],CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,128.0
119787,,,5219896,[],CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119788,,,5219902,[],CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119789,,,5219908,[],CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119790,,,5219914,[],CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,128.0
119791,,,5219920,[],CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,128.0
119792,,,5219926,[],CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119793,,,5219932,[],CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119794,,,5219938,[],CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119795,,,5221014,[],CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119796,,,5221020,[],CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119797,,,5221026,[],CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119798,,,5221032,[],CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119799,,,5221038,[],CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119800,,,5221044,[],CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119801,,,5221050,[],CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119802,,,5221056,[],CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119803,,,5221062,[],CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119804,,,5221068,[],CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,,MIC90,ug ml-1,UO_0000274,,128.0
119805,,,5221074,[],CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,128.0
119806,,,5221080,[],CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,128.0
119807,,,5221105,[],CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC,ug ml-1,UO_0000274,,128.0
119808,,,5221111,[],CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,128.0
119809,,,5221117,[],CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,128.0
119810,,,5221123,[],CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,128.0
119811,,,5221129,[],CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,128.0
119812,,,5221135,[],CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC,ug ml-1,UO_0000274,,128.0
119813,,,5221141,[],CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC,ug ml-1,UO_0000274,,128.0
119814,,,5221147,[],CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC,ug ml-1,UO_0000274,,128.0
119815,,,5221153,[],CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC,ug ml-1,UO_0000274,,128.0
119816,,,5221159,[],CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC,ug ml-1,UO_0000274,,128.0
119817,,,5221165,[],CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,,MIC,ug ml-1,UO_0000274,,128.0
119818,,,5221171,[],CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC,ug ml-1,UO_0000274,,128.0
119819,,,5221177,[],CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC,ug ml-1,UO_0000274,,128.0
119820,,,5221183,[],CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC,ug ml-1,UO_0000274,,128.0
119821,,,5221189,[],CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,,MIC,ug ml-1,UO_0000274,,128.0
119822,,,5221195,[],CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC,ug ml-1,UO_0000274,,128.0
119823,,,5221201,[],CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,128.0
119824,,,5221207,[],CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,,MIC,ug ml-1,UO_0000274,,128.0
119825,,,5221213,[],CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,128.0
119826,,,5221219,[],CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331997,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,128.0
119827,,,5227141,[],CHEMBL1678009,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119828,,,5227147,[],CHEMBL1678009,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.03
119829,,,5227153,[],CHEMBL1678008,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119830,,,5227159,[],CHEMBL1678008,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119831,,,5227165,[],CHEMBL1678008,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
119832,,,5227171,[],CHEMBL1678007,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119833,,,5227177,[],CHEMBL1678007,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,1.0
119834,,,5227183,[],CHEMBL1678007,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
119835,,,5227189,[],CHEMBL1678006,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
119836,,,5227195,[],CHEMBL1678006,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119837,,,5227201,[],CHEMBL1678006,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
119838,,,5227207,[],CHEMBL1677519,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119839,,,5227213,[],CHEMBL1677519,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
119840,,,5227219,[],CHEMBL1677519,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119841,,,5227228,[],CHEMBL1678009,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
119842,,,5227234,[],CHEMBL1678010,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
119843,,,5227240,[],CHEMBL1678010,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119844,,,5227246,[],CHEMBL1678010,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119845,,,5227252,[],CHEMBL1678011,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
119846,,,5227258,[],CHEMBL1678011,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119847,,,5227264,[],CHEMBL1678011,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
119848,,,5227270,[],CHEMBL1678012,Antimicrobial activity against vancomycin-resistant Enterococcus faecium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
119849,,,5227276,[],CHEMBL1678012,Antimicrobial activity against vancomycin-resistant Enterococcus faecium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119850,,,5227282,[],CHEMBL1678012,Antimicrobial activity against vancomycin-resistant Enterococcus faecium by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119851,,,5227288,[],CHEMBL1678013,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
119852,,,5227294,[],CHEMBL1678013,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119853,,,5227300,[],CHEMBL1678013,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119854,,,5227306,[],CHEMBL1678014,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
119855,,,5227312,[],CHEMBL1678014,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
119856,,,5227318,[],CHEMBL1678014,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119857,,,5227324,[],CHEMBL1678015,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
119858,,,5227330,[],CHEMBL1678015,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
119859,,,5227336,[],CHEMBL1678015,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.06
119860,,,5227342,[],CHEMBL1678016,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.03
119861,,,5227348,[],CHEMBL1678016,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,2.0
119862,,,5227354,[],CHEMBL1678016,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332494,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.5
119863,,Active,5300814,[],CHEMBL1696232,"Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119864,,,5300820,[],CHEMBL1696223,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 using BHI broth by macrodilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338453,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,ug ml-1,UO_0000274,,2.0
119865,,,5300821,[],CHEMBL1696224,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 using BHI broth by macrodilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338453,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,ug ml-1,UO_0000274,,2.0
119866,,,5300822,[],CHEMBL1696225,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 using BHI broth by macrodilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338453,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,ug ml-1,UO_0000274,,2.0
119867,,Active,5300830,[],CHEMBL1696226,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119868,,Active,5300831,[],CHEMBL1696227,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119869,,Active,5300832,[],CHEMBL1696228,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119870,,Active,5300833,[],CHEMBL1696229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as increase in cell size at 1 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119871,,Active,5300834,[],CHEMBL1696230,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as increase in cell size at 1 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119872,,Active,5300835,[],CHEMBL1696231,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as increase in cell size at 1 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119873,,Active,5300841,[],CHEMBL1696233,"Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119874,,Active,5300845,[],CHEMBL1696234,"Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119875,,Active,5300847,[],CHEMBL1696235,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as change in CFU count at 1 times MIC after 30 to 90 mins,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119876,,Active,5300848,[],CHEMBL1696236,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as change in CFU count at 1 times MIC after 30 to 90 mins,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119877,,Active,5300849,[],CHEMBL1696237,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as change in CFU count at 1 times MIC after 30 to 90 mins,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119878,,Not Active,5300852,[],CHEMBL1696238,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119879,,Not Active,5300856,[],CHEMBL1696239,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119880,,Not Active,5300860,[],CHEMBL1696240,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119881,,Active,5300864,[],CHEMBL1696245,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119882,,Active,5300868,[],CHEMBL1696246,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119883,,Active,5300872,[],CHEMBL1696247,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
119884,,,5300874,[],CHEMBL1696241,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as cells with altered cell wall morphology at 8 times MIC after 60 mins,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1338453,>,1,0,>,,Activity,%,,90.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,90.0
119885,,Active,5300881,[],CHEMBL1696242,Drug uptake in vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Drug uptake,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Drug uptake,,,,
119886,,Active,5300882,[],CHEMBL1696243,Drug uptake in vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Drug uptake,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Drug uptake,,,,
119887,,Active,5300883,[],CHEMBL1696244,Drug uptake in vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1338453,,1,0,,,Drug uptake,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Drug uptake,,,,
119888,,,5302674,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/ml,UO_0000274,,1.0
119889,,,5302675,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,mg/ml,UO_0000274,,1.0
119890,,,5302676,[],CHEMBL1695193,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119891,,,5302677,[],CHEMBL1695194,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119892,,,5302678,[],CHEMBL1695199,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
119893,,,5302679,[],CHEMBL1695192,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
119894,,,5302680,[],CHEMBL1695191,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate NY after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
119895,,,5302681,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/ml,UO_0000274,,1.0
119896,,,5302682,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/ml,UO_0000274,,1.0
119897,,,5302683,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,mg/ml,UO_0000274,,1.0
119898,,,5302684,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC50,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/ml,UO_0000274,,1.0
119899,,,5302685,[],CHEMBL1690635,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119900,,,5302686,[],CHEMBL1690636,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
119901,,,5302687,[],CHEMBL1690637,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
119902,,,5302688,[],CHEMBL1690638,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
119903,,,5302689,[],CHEMBL1690639,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate NY after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
119904,,,5302690,[],CHEMBL1690645,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,3.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.02
119905,,,5302691,[],CHEMBL1690646,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.82,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.82
119906,,,5302692,[],CHEMBL1690647,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.12
119907,,,5302693,[],CHEMBL1690648,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.12
119908,,,5302694,[],CHEMBL1690649,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,3.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.61
119909,,,5302695,[],CHEMBL1690650,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,3.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.86
119910,,,5302696,[],CHEMBL1690651,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.68,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.68
119911,,,5302697,[],CHEMBL1690652,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.93,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.93
119912,,,5302698,[],CHEMBL1690653,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.01,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.01
119913,,,5302699,[],CHEMBL1690654,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.13
119914,,,5302700,[],CHEMBL1690655,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.09
119915,,,5302701,[],CHEMBL1690656,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.23,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.23
119916,,,5302702,[],CHEMBL1690657,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.78
119917,,,5302703,[],CHEMBL1690658,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.01,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.01
119918,,,5302704,[],CHEMBL1690659,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.03
119919,,,5302705,[],CHEMBL1690660,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.04
119920,,,5302706,[],CHEMBL1690661,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.59,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.59
119921,,,5302707,[],CHEMBL1690662,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.0
119922,,,5302708,[],CHEMBL1690663,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.96,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.96
119923,,,5302709,[],CHEMBL1690664,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.03
119924,,,5302710,[],CHEMBL1690665,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,3.33,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.33
119925,,,5302711,[],CHEMBL1690666,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.95
119926,,,5302712,[],CHEMBL1690774,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.14,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.14
119927,,,5302713,[],CHEMBL1690775,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.1
119928,,,5302714,[],CHEMBL1690776,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,2.53,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.53
119929,,,5302715,[],CHEMBL1690777,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.69,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.69
119930,,,5302716,[],CHEMBL1690778,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,4.6
119931,,,5302717,[],CHEMBL1690779,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.11,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.11
119932,,,5302718,[],CHEMBL1690780,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 4 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.12
119933,,,5302719,[],CHEMBL1690781,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 8 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.11,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.11
119934,,,5302720,[],CHEMBL1690782,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 16 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.12
119935,,,5302721,[],CHEMBL1690783,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA assessed as bacterial count at 32 times MIC after 24 hrs by colony counting method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,log10CFU/ml,,,5.11,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,5.11
119936,,,5302777,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/ml,UO_0000274,,1.0
119937,,,5302778,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,1000.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,mg/ml,UO_0000274,,1.0
119938,,,5302779,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/ml,UO_0000274,,1.0
119939,,,5302780,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,0.25
119940,,,5302781,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,mg/ml,UO_0000274,,0.25
119941,,,5302782,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,0.25
119942,,,5302783,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,mg/ml,,,1.0
119943,,,5302784,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC50,mg/ml,,,1.0
119944,,,5302785,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,mg/ml,,,1.0
119945,,,5302786,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,mg/ml,,,2.0
119946,,,5302787,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC90,mg/ml,,,2.0
119947,,,5302788,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,mg/ml,,,2.0
119948,,,5302789,[],CHEMBL1695195,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/ml,,,0.25
119949,,,5302790,[],CHEMBL1695197,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC,mg/ml,,,0.25
119950,,,5302791,[],CHEMBL1695198,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/ml,,,0.25
119951,,,5302837,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,4000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/ml,UO_0000274,,4.0
119952,,,5302838,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,4000.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,mg/ml,UO_0000274,,4.0
119953,,,5302839,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC90,ug.mL-1,,4000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/ml,UO_0000274,,4.0
119954,,,5302840,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,0.25
119955,,,5302841,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,mg/ml,UO_0000274,,0.25
119956,,,5302842,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,0.25
119957,,,5302843,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,mg/ml,,,4.0
119958,,,5302844,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC50,mg/ml,,,4.0
119959,,,5302845,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC50,mg/ml,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,mg/ml,,,4.0
119960,,,5302846,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,mg/ml,,,8.0
119961,,,5302847,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC90,mg/ml,,,8.0
119962,,,5302848,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC90,mg/ml,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,mg/ml,,,8.0
119963,,,5302849,[],CHEMBL1695196,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/ml,,,1.0
119964,,,5302850,[],CHEMBL1695200,Antimicrobial activity against vancomycin-intermediate Staphylococcus haemolyticus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC,mg/ml,,,1.0
119965,,,5302851,[],CHEMBL1690634,Antimicrobial activity against vancomycin-heteroresistant Staphylococcus aureus after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,MBC,mg/ml,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/ml,,,1.0
119966,,,5302857,[],CHEMBL1695193,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
119967,,,5302858,[],CHEMBL1695194,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
119968,,,5302859,[],CHEMBL1695199,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
119969,,,5302860,[],CHEMBL1695192,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
119970,,,5302861,[],CHEMBL1695191,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate NY after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
119971,,,5302877,[],CHEMBL1690635,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate PA after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
119972,,,5302878,[],CHEMBL1690636,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate MI after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
119973,,,5302879,[],CHEMBL1690637,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate MU50 after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
119974,,,5302880,[],CHEMBL1690638,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus isolate NJ992 after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
119975,,,5302881,[],CHEMBL1690639,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus isolate NY after 24 hrs by microdilution method in presence of 50% human serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337816,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
119976,,,5302893,[],CHEMBL1690788,Ratio of MIC for vancomycin-intermediate Staphylococcus aureus in presence of 50% human serum to MIC for vancomycin-intermediate Staphylococcus aureus,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119977,,,5302894,[],CHEMBL1690789,Ratio of MIC for vancomycin-intermediate Staphylococcus haemolyticus in presence of 50% human serum to MIC for vancomycin-intermediate Staphylococcus haemolyticus,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Ratio,,,,2.0
119978,,,5302895,[],CHEMBL1690790,Ratio of MIC for vancomycin-heteroresistant Staphylococcus aureus in presence of 50% human serum to MIC for vancomycin-heteroresistant Staphylococcus aureus,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119979,,,5302896,[],CHEMBL1690640,Ratio of MIC for vancomycin-intermediate Staphylococcus aureus isolate MU50 in presence of 50% human serum to MIC for vancomycin-intermediate Staphylococcus aureus isolate MU50,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119980,,,5302897,[],CHEMBL1690641,Ratio of MIC for vancomycin-resistant Staphylococcus aureus isolate PA in presence of 50% human serum to MIC for vancomycin-resistant Staphylococcus aureus isolate PA,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119981,,,5302898,[],CHEMBL1690642,Ratio of MIC for vancomycin-intermediate Staphylococcus aureus isolate NJ992 in presence of 50% human serum to MIC for vancomycin-intermediate Staphylococcus aureus isolate NJ992,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119982,,,5302899,[],CHEMBL1690643,Ratio of MIC for vancomycin-resistant Staphylococcus aureus isolate MI in presence of 50% human serum to MIC for vancomycin-resistant Staphylococcus aureus MI,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119983,,,5302900,[],CHEMBL1690644,Ratio of MIC for vancomycin-resistant Staphylococcus aureus isolate NY in presence of 50% human serum to MIC for vancomycin-resistant Staphylococcus aureus NY,F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337816,=,1,0,=,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
119984,,,5302903,[],CHEMBL1690785,Plasma protein binding in human in presence of human serum,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687766,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://qudt.org/vocab/unit#Percent,1337816,=,1,1,=,,PPB,%,,92.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,92.0
119985,,,5304147,[],CHEMBL1690070,Antimicrobial activity against Bacillus anthracis Ames by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337838,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,0.5
119986,,,5304148,[],CHEMBL1690070,Antimicrobial activity against Bacillus anthracis Ames by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC50,ug ml-1,UO_0000274,,2.0
119987,,,5304149,[],CHEMBL1690070,Antimicrobial activity against Bacillus anthracis Ames by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC90,ug ml-1,UO_0000274,,4.0
119988,,Active,5304150,[],CHEMBL1690071,"Antimicrobial activity against Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model assessed as decrease in tissue bacterial burden at 50 mg/kg, sc bid for 14 days administered 24 hrs post bacterial challenge measured 43 days post bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
119989,,Active,5304151,[],CHEMBL1690072,"Antimicrobial activity against Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model assessed as decrease in tissue bacterial burden at 50 mg/kg, sc bid for 21 days administered 24 hrs post bacterial challenge measured 43 days post bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
119990,,,5304152,[],CHEMBL1690075,"AUC in Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model at 50 mg/kg, sc bid for 14 days administered 24 hrs post bacterial challenge",F,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,>,1,1,>,,AUC,ng.hr.mL-1,,375000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,375.0
119991,,,5304153,[],CHEMBL1690076,"AUC at 24 hrs in Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model at 50 mg/kg, sc bid for 14 days administered 24 hrs post bacterial challenge",F,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,=,1,1,=,,AUC,ng.hr.mL-1,,750000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/L,,,750.0
119992,,,5304154,"[{'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1690078,AUC (0 to 24 hrs) in human,A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,=,1,1,=,,AUC,ng.hr.mL-1,,494000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,mg.hr/L,,,494.0
119993,,,5304155,[],CHEMBL1690077,Ratio of AUC at 24 hrs in in Bacillus anthracis Ames infected BALB/c mouse anthrax spore inhalation model to MIC for Bacillus anthracis Ames,F,,,BAO_0000193,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337838,=,1,0,=,,Ratio,,,375.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,375.0
119994,,Active,5305347,[],CHEMBL1696165,Induction of promoter liaI in Bacillus subtilis at 0.5 to 2 ug/ml,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
119995,,,5305349,[],CHEMBL1696164,Induction of liaH gene expression in Bacillus subtilis by real-time RT-PCR,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,=,1,0,=,,FC,,,1170.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,FC,,,,1170.0
119996,,,5305351,[],CHEMBL1696163,Induction of ylaC gene expression in Bacillus subtilis by real-time RT-PCR,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,=,1,0,=,,FC,,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,FC,,,,1.0
119997,,,5305353,[],CHEMBL1696162,Induction of sigZ gene expression in Bacillus subtilis by real-time RT-PCR,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,=,1,0,=,,FC,,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,FC,,,,1.0
119998,,,5305355,[],CHEMBL1696161,Induction of sigY gene expression in Bacillus subtilis by real-time RT-PCR,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,=,1,0,=,,FC,,,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,FC,,,,0.9
119999,,,5305357,[],CHEMBL1696160,Induction of sigX gene expression in Bacillus subtilis by real-time RT-PCR,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,,,CHEMBL1687728,Antimicrob Agents Chemother,2009.0,,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,,0,,1337302,=,1,0,=,,FC,,,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,FC,,,,0.8
